DE69935976D1 - Prävention und therapie von leberzirrhosen - Google Patents

Prävention und therapie von leberzirrhosen

Info

Publication number
DE69935976D1
DE69935976D1 DE69935976T DE69935976T DE69935976D1 DE 69935976 D1 DE69935976 D1 DE 69935976D1 DE 69935976 T DE69935976 T DE 69935976T DE 69935976 T DE69935976 T DE 69935976T DE 69935976 D1 DE69935976 D1 DE 69935976D1
Authority
DE
Germany
Prior art keywords
croppes
liver
therapy
prevention
preventives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69935976T
Other languages
English (en)
Inventor
Yoshiyuki Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69935976D1 publication Critical patent/DE69935976D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69935976T 1998-05-14 1999-05-13 Prävention und therapie von leberzirrhosen Expired - Lifetime DE69935976D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13177198 1998-05-14
PCT/JP1999/002477 WO1999058150A1 (fr) 1998-05-14 1999-05-13 Agents preventifs/remedes contre la cirrhose du foie

Publications (1)

Publication Number Publication Date
DE69935976D1 true DE69935976D1 (de) 2007-06-14

Family

ID=15065784

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935976T Expired - Lifetime DE69935976D1 (de) 1998-05-14 1999-05-13 Prävention und therapie von leberzirrhosen

Country Status (5)

Country Link
EP (1) EP1077069B1 (de)
AT (1) ATE361119T1 (de)
CA (1) CA2328601A1 (de)
DE (1) DE69935976D1 (de)
WO (1) WO1999058150A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08127594A (ja) * 1993-11-10 1996-05-21 Mochida Pharmaceut Co Ltd Ｆａｓ抗原に結合する新規蛋白質およびそれをコードするＤＮＡ
EP0842948B1 (de) * 1995-06-30 2009-04-22 Mochida Pharmaceutical Co., Ltd. ANTI-Fas-LIGAND ANTIKÖRPER UND TESTMETHODE UNTER VERWENDUNG DERSELBEN
JPH0972901A (ja) * 1995-09-01 1997-03-18 Nippon Dpc Corp 肝疾患群の評価法
JPH09124509A (ja) * 1995-10-27 1997-05-13 Sumitomo Electric Ind Ltd 肝炎治療剤
WO1997042319A1 (fr) * 1996-05-02 1997-11-13 Mochida Pharmaceutical Co., Ltd. NOUVEAUX DERIVES DE L'ANTIGENE Fas

Also Published As

Publication number Publication date
ATE361119T1 (de) 2007-05-15
EP1077069A4 (de) 2004-06-16
WO1999058150A1 (fr) 1999-11-18
EP1077069B1 (de) 2007-05-02
EP1077069A1 (de) 2001-02-21
CA2328601A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
CY1110309T1 (el) Φαρμακευτικες συνθεσεις για την προληψη και την αγωγη διαταραχων του κεντρικου νευρικου συστηματος περιλαμβανοντας ενα αναλογο νικοτινης και εναν αναστολεα ακετυλχολινεστερασης
SE9901272D0 (sv) New improved formulation
DE69838099D1 (de) Quinazolinenon-enthaltende pharmazeutische zusammensetzungen zur verhütung von gefässneubildung und zur behandlung von bösartigen neubildungen
PL373903A1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
BR9813228A (pt) Formulação de 2-metil-tieno-benzodiazepina
ES2133270T3 (es) Terapia de combinacion para la profilaxis y/o el tratamiento de hiperplasia prostatica benigna.
NO942650L (no) Farmasöytisk kombinasjonspreparat
FI951856A0 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
ID29547A (id) Metoda dan komposisi untuk pencegahan dan pengobatan tuberkulosis
UA66872C2 (uk) Сполука, яка є памоатом оланзапіну або його сольватом, та спосіб лікування психотичних розладів
BR9916432A (pt) Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
ATE469642T1 (de) Vorbeugungs- oder heilmittel gegen endometriose
BR9811937A (pt) Método de aumentar a biodisponibilidade de fexofenadina e de seus derivados
DE69935976D1 (de) Prävention und therapie von leberzirrhosen
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
BG102716A (en) Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline
BR0015121A (pt) Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação
DE69928685D1 (de) Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit
ATE333287T1 (de) Prophylaxe und behandlung von autoimmunen entmyelinisierungserkrankungen durch fas- antagonisten
BR0003648A (pt) Composições e métodos para tratar condições alérgicas e inflamatórias com tosse
NO994930D0 (no) Preventiver og hjelpemidler for ulcerös kolitt og/eller crohn's sykdom
IL127102A0 (en) Pharmaceutical compositions for the treatment of dyskinesias

Legal Events

Date Code Title Description
8332 No legal effect for de